Sitagliptin (Aschner et al., 2006), saxagliptin (Rosenstock et al., 2009), and vildagliptin (Keating, 2010) all improve glucose metabolism in diabetic patients
Ask for: A written estimate for medication, supplies, and monitoring Clear expectations on visit frequency and lab timing Help using savings programs or comparing local pharmacy prices A maintenance plan so you are not paying for more medication than you need The most affordable path is the one you can maintain comfortably and safely
Similarly, individuals with pre-existing cardiovascular conditions should discuss the use of BPC-157 with their healthcare provider
The obesity and diabetes epidemic is driving demand for GLP-1 medications, with a projected value size of USD 4.1 billion in 2025
A provider can review your medical history, current medications, weight management goals, and whether this type of treatment may be appropriate